Stock Groups

Eli Lilly raises 2021 profit forecast -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: A branchburg pharmaceutical manufacturing plant of Eli Lilly and Company can be seen at 50 ImClone Dr in Branchburg (New Jersey), March 5, 2021. REUTERS/Mike Segar

(Reuters] – Eli Lilly’s full-year 2020 profit and forecast for sales were raised on Wednesday by the NYSE. The increase was partially due to a U.S. contract that covered its COVID-19 treatment.

Lilly indicated that adjusted earnings per share will be between $8.15 to $8.20. This compares to the earlier range of $7.95 – $8.05.

It expects that 2021 revenue will range from $28.0 billion up to $28.3billion, an increase of its earlier forecast of $27.2 billion-$27.6 billion.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]